The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Adrenoleukodystrophy: Elevated C26 fatty acid in cultured skin fibroblasts
Abstract
Because postmortem brain and adrenal tissue from patients with adrenoleukodystrophy (ALD) or adrenomyeloneuropathy (AMN) have been shown to contain abnormally large amounts of very long chain fatty acids (C 24 through C 30), we searched for such an abnormality in cultured skin fibroblasts. Total lipid extracts of cultured fibroblasts were hydrolyzed, their fatty acid composition was derermined by gas‐liquid chromatography, and the ratio of C 26 to C 22 fatty acids was calculated. In 29 control cell lines this ratio was 0.064 ± 0.019. In 5 patients with autopsy‐proved ALD the ratio was 0.778 ± 0.139; in 6 patients with clinical features typical of ALD it was 0.764 ± 0.092; in 2 patients with autopsy‐proved AMN, 0.890 ± 0.02; and in 2 patients with clinical features typical of AMN, 0.560 ± 0.079. Abnormal ratios were observed in 4 of 5 ALD heterozygotes. In 3 patients in whom the diagnosis of ALD was suspected, an abnormal ratio (0.860) was observed in 1 and normal ratios (0.06 and 0.074) in the 2 others.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Qualitative alteration in substrate specificity of mitochondrial monoamine oxidase in brain
Moskvitina, T. A., Kamyshanskaya, N. S., Kaverina, L. P., & Gorkin, V. Z. (1976) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1976.tb04462.x · Cited by 440
Schaumburg (1977) · doi:10.1212/wnl.27.12.1114 · Cited by 166
Fatty acid abnormality in adrenoleukodystrophy
Igarashi, M., Schaumburg, H. H., Powers, J., Kishimoto, Y., Koilodny, E., & Suzuki, K. (1976) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1976.tb04461.x-i1 · Cited by 134
Self-citationSchaumburg, H. H. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490390092013 · Cited by 89
Self-citationAdrenoleukodystrophy: Electron Microscopic Findings
Powell, H. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490460066009 · Cited by 76
Metabolic Studies of Adrenoleukodystrophy
Ogino, T., Schaumburg, H. H., Suzuki, K., Kishimoto, Y., & Moser, A. E. (1978) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4684-2514-7_44 · Cited by 22
Self-citation
Cited by
Moser, H. W., Mahmood, A., & Raymond, G. V. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0421 · Cited by 663
Self-citationDodt, G., Braverman, N., Wong, C., Moser, A., Moser, H. W., Watkins, P., Valle, D., & Gould, S. J. (1995) · Nature Genetics · doi:10.1038/ng0295-115 · Cited by 424
Self-citationMoser, H. (1981) · doi:10.1212/wnl.31.10.1241 · Cited by 396
Self-citationPeroxisomal disorders: A newly recognised group of genetic diseases
Schutgens, R. B. H., Heymans, H. S. A., Wanders, R. J. A., Bosch, H. V. D., & Tager, J. M. (1986) · European Journal of Pediatrics · doi:10.1007/bf00441734 · Cited by 312
A mouse model for X-linked adrenoleukodystrophy
Lu, J.-F., Lawler, A. M., Watkins, P. A., Powers, J. M., Moser, A. B., Moser, H. W., & Smith, K. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9366 · Cited by 293
Self-citationMigeon, B. R., Moser, H. W., Moser, A. B., Axelman, J., Sillence, D., & Norum, R. A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.5066 · Cited by 282
Self-citationPeroxisomal disorders: The single peroxisomal enzyme deficiencies
Wanders, R. J. A., & Waterham, H. R. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.08.010 · Cited by 279
Moser, A. E., Singh, I., Brown, F. R., Solish, G. I., Kelley, R. I., Benke, P. J., & Moser, H. W. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405033101802 · Cited by 271
Self-citationAdrenoleukodystrophy: Survey of 303 cases: Biochemistry, diagnosis, and therapy
Moser, H. W., Moser, A. E., Singh, I., & O'Neill, P. (1984) · Annals of Neurology · doi:10.1002/ana.410160603 · Cited by 259
Self-citationSingh, I., Moser, A. E., Moser, H. W., & Kishimoto, Y. (1984) · Pediatric Research · doi:10.1203/00006450-198403000-00016 · Cited by 234
Self-citationVery long chain fatty acids in higher animals: a review
Poulos, A. (1995) · Lipids · doi:10.1007/bf02537036 · Cited by 192
X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy
van Geel, B. M., Assies, J., Wanders, R. J. A., & Barth, P. G. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.1.4 · Cited by 162
Biochemical abnormalities in rhizomelic chondrodysplasia punctata
Hoefler, G., Hoefler, S., Watkins, P. A., Chen, W. W., Moser, A., Baldwin, V., McGillivary, B., Charrow, J., Friedman, J. M., Rutledge, L., et al. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80689-9 · Cited by 133
Self-citationvan Geel, B. M., Assies, J., Haverkort, E. B., Koelman, J. H. T. M., Verbeeten, B., Wanders, R. J. A., & Barth, P. G. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.3.290 · Cited by 131
Altered expression of ALDP in X-linked adrenoleukodystrophy.
(1995) · PubMed Central · Cited by 127
Lipid metabolism in peroxisomes in relation to human disease
Wanders, R. J. A., & Tager, J. M. (1998) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(98)00003-x · Cited by 122
Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients
Jang, J., Kang, H., Kim, H., Kim, J. Y., Huh, Y. J., Kim, D., Yoo, J., Lee, J., Lim, B., Lee, J., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22486 · Cited by 109
Laureti, S., Casucci, G., Santeusanio, F., Angeletti, G., Aubourg, P., & Brunetti, P. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.2.8636252 · Cited by 101
Identification of female carriers of adrenoleukodystrophy
Moser, H. W., Moser, A. E., Trojak, J. E., & Supplee, S. W. (1983) · The Journal of Pediatrics · doi:10.1016/s0022-3476(83)80775-6 · Cited by 99
Self-citationPeroxisomal fatty acid β-oxidation in HepG2 cells
Watkins, P. A., Ferrell, E. V., Pedersen, J. I., & Hoefler, G. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90419-j · Cited by 86
Peroxisomal ABC Transporters: An Update
Tawbeh, A., Gondcaille, C., Trompier, D., & Savary, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116093 · Cited by 68
Höftberger, R., Kunze, M., Weinhofer, I., Aboul-Enein, F., Voigtländer, T., Oezen, I., Amann, G., Bernheimer, H., Budka, H., & Berger, J. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.007 · Cited by 69
“The biochemical hallmark of X-ALD is an accumulation of very long chain fatty acids (VLCFAs), predominantly C26:0, in tissues and blood (Moser et al., 1980, 1981; Rasmussen et al., 1994).”
BackgroundLipid and fatty acid composition of brain tissue from adrenoleukodystrophy patients
Wilson, R., & Sargent, J. R. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03567.x · Cited by 67
AUBOURG, P., & MANDEL, J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18637.x · Cited by 58
Bernheimer, H., Budka, H., & M�ller, P. (1983) · Acta Neuropathologica · doi:10.1007/bf00691593 · Cited by 54
Fetal adrenoleukodystrophy: the significance of pathologic lesions in adrenal gland and testis
Powers, J. M., Moser, H. W., Moser, A. B., & Schaumburg, H. H. (1982) · Human Pathology · doi:10.1016/s0046-8177(82)80093-2 · Cited by 49
Self-citationAubourg, P., Bougnères, P. F., & Rocchiccioli, F. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34397-2 · Cited by 45
Theda, C., Woody, R. C., Naidu, S., Moser, A. B., & Moser, H. W. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(06)80013-2 · Cited by 44
Self-citationMatsukawa, T., Asheuer, M., Takahashi, Y., Goto, J., Suzuki, Y., Shimozawa, N., Takano, H., Onodera, O., Nishizawa, M., Aubourg, P., et al. (2011) · neurogenetics · doi:10.1007/s10048-010-0253-6 · Cited by 36
Cerebral X‐linked adrenoleukodystrophy in a girl with Xq27‐Ter deletion
Hershkovitz, E., Narkis, G., Shorer, Z., Moser, A. B., Watkins, P. A., Moser, H. W., & Manor, E. (2002) · Annals of Neurology · doi:10.1002/ana.10248 · Cited by 30
Self-citationAdrenomyeloneuropathy: A report on two families
Martin, J. J., Lowenthal, A., Ceuterick, C., & Gacoms, H. (1982) · Journal of Neurology · doi:10.1007/bf00313395 · Cited by 27
Delay in diagnosis of X-linked adrenoleukodystrophy
van Geel, B. M., Assies, J., Haverkort, E. B., Barth, P. G., Wanders, R. J. A., Schutgens, R. B. H., Keyser, A., & Zwetsloot, C. P. (1993) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(93)90004-z · Cited by 26
Adrenoleukodystrophy: biochemical procedures in diagnosis, prevention and treatment
Watkins, P. A., Naidu, S., & Moser, H. W. (1987) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01812846 · Cited by 20
Self-citationThe pathology of X-linked adrenoleukodystrophy: Tissue specific changes as a clue to pathophysiology
Yska, H. A. F., Engelen, M., & Bugiani, M. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03105-0 · Cited by 20
Imbalanced mitochondrial dynamics contributes to the pathogenesis of X-linked adrenoleukodystrophy
Launay, N., Lopez-Erauskin, J., Bianchi, P., Guha, S., Parameswaran, J., Coppa, A., Torreni, L., Schlüter, A., Fourcade, S., Paredes-Fuentes, A. J., et al. (2024) · Brain · doi:10.1093/brain/awae038 · Cited by 14
Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy
Bougnères, P., & Le Stunff, C. (2025) · Genes · doi:10.3390/genes16050590 · Cited by 11
Metadata
- Authors
- Moser, H. W., Moser, A. B., Kawamura, N., Murphy, J., Suzuki, K., Schaumburg, H., & Kishimoto, Y.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1980-06
- Volume
- 7
- Issue
- 6
- Pages
- 542-549
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2064716240
- Cited by
- 210
- References
- 6
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.